Abstract:Objective:To compare the expression of serum soluble Fas(sFas) and serum soluble FasL(sFasL) between the healthy controls and patients with systemic lupus erythematosus(SLE),to analysis the relationship of the sFas,sFasL and the organ or system damage in SLE,and to define the role of apoptosis in the relationship.Methods:SLE patients(n=68) were selectedfrom two hospitals,and normal healthy volunteers(n=69) were recruited as controls.General information and the data of organ or system damage were collected by self-designed questionnaire containing the Systemic Lupus International Collaborative Clinics/American College of Rheumatology Damage Index(SLICC/ACR DI).Annexin V(AV) and propidium iodide(PI) were used to detect the early apoptosis rate of peripheral blood mononuclear cells(PBMCs).Serum sFas andsFasL were measured using Sandwich-ELISA.Results:Patients with SLE had a higher level of sFas(n=68,6876.27±1979.38 pg/ml) compared to healthy controls(n=69,3275.08±1023.01 pg/ml)(t=13.405,P<0.01),and the level had a positive correlation with SLEDAI(r=0.274,t=2.86,P=0.005),SLICC/ACR DI(rs=0.437,t=3.95,P<0.01),as well as the early apoptosis rate of PBMCs(r=0.395,t=3.49,P<0.01) in SLE.The association between the serum sFas levels and various organ and tissue damages was also investigated.There was a significant difference in the serum sFas levels between patients with and without CNS disease(9576.60±3654.70 pg/ml,6629.37±2372.30 pg/ml;q=6.42,P<0.05).Similarly,we observed a significant difference in the serum sFas levels between patients with and without renal disease(10968.45±4814.60 pg/ml,6502.78±3971.00 pg/ml;q=8.20,P<0.055).The same was true when patients with and without serositis(10376.69±4149.50 pg/ml,6718.34±2351.80 pg/ml;q=6.30,P<0.05) were analyzed.Conclusion:The expression of sFas is increased among patients with SLE,and the sFas level have close relationship with the organ or system damage in SLE.High expression of sFas and high apoptosis rate are likely to involve in the pathogenesis of SLE.sFas is a potential predictor for organ or system damage of SLE.

The correlation between quantitative expression of Fas receptor molecules on CD3+ T lymphocyte and disease activity of systemic lupus erythematosus

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

The significance of quantitative measurement of Fas receptor molecules expression on T lymphocytes surface in the treatment of systemic lupus erythematosus

Peripheral CD24hi CD27+ CD19+ B Cells Subset As a Potential Biomarker in Naïve Systemic Lupus Erythematosus.

[Clinical Significance of CD4+CD25+ T Cells in Peripheral Blood of Patients in Systemic Lupus Erythematosus].

Abnormal Expression of Cd43 in Patients with Systemic Lupus Erythematosus and Its Clinical Significance

Aberrant CD200/CD200R1 Expression and Function in Systemic Lupus Erythematosus Contributes to Abnormal T-cell Responsiveness and Dendritic Cell Activity

Changes in the Expression of Fas on T Lymphocytes after Allogeneic Fetal Thymus Transplantation in Systemic Lupus Erytematosus Mice.

Association of serum soluble Fas,apoptosis and indices of the damage of organ or system in systemic lupus erythematosus

lncRNA X-inactive-specific transcript is a potential biomarker related to changes in CD4 + T cell levels in systemic lupus erythematosus

Expressions of BAFF/BAFF Receptors and Their Correlation with Disease Activity in Chinese SLE Patients

Significance of CD69/CD3 Ratio of Peripheral Blood Mononuclear Cells As a Marker for Evaluating the Disease Activity of Systemic Lupus Erythematosus

Study of T-lymphocyte Activation and Correlation with Disease Activity in Patients with Systemic Lupus Erythematosus

Frequency and Significance of CD4+CD25+T Cell Subpopulations in the Peripheral Blood of Patients with Systemic Lupus Erythematosus

Elevated Apoptosis and Impaired Proliferation Contribute to Downregulated PeripheralγδT Cells in Patients with Systemic Lupus Erythematosus

Expression level of Interferon regulatory factor 5 in systemic lupus erythematosus

[Role of Circulating T Follicular Helper Subsets and T Follicular Helper Effector Memory Cells in Systemic Lupus Erythematosus].

Study on the Relationship of Apoptosis and Titer of Dsdna Antibody in Systemic Lupus Erythematosus

Identification and Characterization of CD8+CD27+CXCR3− T Cell Dysregulation and Progression‐Associated Biomarkers in Systemic Lupus Erythematosus

Associations of Circulating CXCR3–PD-1+CD4+T Cells with Disease Activity of Systemic Lupus Erythematosus